AI assistant
Standard Chartered PLC — Director's Dealing 2018
Sep 12, 2018
4648_dirs_2018-09-12_448af72b-1ef3-400f-b7b8-9fa0a1e7701c.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6020A
Standard Chartered PLC
12 September 2018
Standard Chartered PLC - Director/PDMR Shareholding
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Judy Hsu
2
Reason for the notification
a)
Position/status
Regional CEO, ASEAN & South Asia
b)
Initial notification /Amendment
Initial
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Standard Chartered PLC
b)
LEI
U4LOSYZ7YG4W3S5F2G91
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of US$0.50 each
ISIN: GB0004082847
b)
Nature of the transaction
i) Application of notional dividend shares to deferred shares granted in March 2016 under the 2011 Standard Chartered Share Plan
ii) Exercise of deferred shares granted in March 2016 under the 2011 Standard Chartered Share Plan, including notional dividends under the transaction described above
c)
Price(s) and volume(s)
| Price £ |
Volume | |
| i) | N/A | 255 |
| ii) | 6.1171 | 16,083 |
d)
Aggregated information
- Aggregated volume
- Price
| Price £ |
Volume | |
| i) | N/A | 255 |
| ii) | 6.1171 | 16,083 |
e)
Date of the transaction
11 September 2018
f)
Place of the transaction
XLON London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHELLFFVKFBBBV